news

A-share midday review: The two markets' half-day turnover was less than 320 billion. New crown drug concept stocks collectively exploded

2024-08-12

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

Cailianshe reported on August 12 that the market fluctuated in a narrow range in the early trading, and the three major indexes all fell slightly. As of the close, the Shanghai Composite Index fell 0.03%, the Shenzhen Component Index fell 0.12%, and the ChiNext Index fell 0.1%.

On the market, pharmaceutical stocks strengthened collectively again, with COVID-19 drugs leading the gains.GuangshengtangXinhua PharmaceuticalDaan GeneKehua BiotechnologyDaily limit up; Chinese medicine stocks fluctuated higher,Teyi PharmaceuticalYiling PharmaceuticalEnvironmental protection stocks opened with a big rise.Qingyan EnvironmentSnow DragonYutong Heavy IndustriesShenwu Energy SavingSmart driving concept stocks rebounded partially, with Qiming Information and Huati Technology hitting their daily limit.

On the downside, real estate stocks fell into adjustment, and many stocks such as Shenzhen Property A fell by more than 5%. Overall, more stocks fell than rose, and more than 3,300 stocks fell in the market. The half-day turnover of the Shanghai and Shenzhen stock markets was 319 billion, a decrease of 46.2 billion from the previous trading day.

In terms of sectors, environmental protection equipment, new crown drugs, traditional Chinese medicine, innovative drugs and other sectors had the largest gains, while real estate, tourism, education, and duty-free sectors had the largest declines.